Dr. K.C.E. Sigaloff MD PhD publications

foto

Publications Dr. K.C.E. Sigaloff MD PhD

Position
PhD student
Main activities
Research
Specialisation
Internal Medicine
Focus of research

HIV drug resistance and delivery of antiretroviral treatment in sub-Saharan Africa

2019

  • Chaplin B, Akanmu AS, Inzaule SC, Samuels JO, Okonkwo P, Ilesanmi O, Adewole IFA, Asadu C, Khamofu H, Mpazanje R, Ndembi N, Odafe S, Sigaloff KCE, Ngige EN, Abatta EO, Akinbiyi G, Dakum P, Rinke de Wit TF, Kanki P, Association between HIV-1 subtype and drug resistance in Nigerian infants. J ANTIMICROB CHEMOTH 2019;74 (1):172-176 [PubMed]

2018

  • Inzaule SC, Hamers RL, Calis J , Boerma R, Sigaloff K, Zeh C, Mugyenyi P, Akanmu S, Rinke de Wit TF, When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children. AIDS 2018;32 (2):143-147 [PubMed]
  • Inzaule SC, Hamers RL, Noguera-Julian M, Casadellà M, Parera M, Kityo C, Steegen K, Naniche D, Clotet B, Rinke de Wit TF, Paredes R [Contributors: Osibogun A, Wallis CL, Nalubwama C, Letsoalo E, Senono F, Adelabu H, Kakooza H, Namata H, Sanne I, Nankya I, Menke J, Lange JMA, Sigaloff KCE, Mandaliya K, Hardman M, Siwale M, de Jager M, Dolan M, Botes ME, O'Mello M, Wellington M, Mutebi M, Nakitto M, Labib M, Pakker N, Ondoa P, Mugyenyi P, Ive P, Nakanjako R, Schuurman R, Lüthy R, Balinda SN, Akanmu S, Boender TS, Adeyemo TA, Rodoye T, Stevens WS, Namala W]] , Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study. LANCET HIV 2018;5 (11):e638-e646 [PubMed]
  • Inzaule SC, Kityo CM, Siwale M, Akanmu AS, Wellington M, de Jager M, Ive P, Mandaliya K, Stevens W, Boender TS, Ondoa P, Sigaloff KCE, Naniche D, Rinke de Wit TF, Hamers RL, Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance. SCI REP-UK 2018;8 (1):15751 [PubMed]
  • Inzaule SC, Osi SJ, Akinbiyi G, Emeka A, Khamofu H, Mpazanje R, Ilesanmi O, Ndembi N, Odafe S, Sigaloff KCE, Rinke de Wit TF, Akanmu S, High Prevalence of HIV Drug Resistance Among Newly Diagnosed Infants Aged <18 Months: Results From a Nationwide Surveillance in Nigeria. JAIDS-J ACQ IMM DEF 2018;77 (1):e1-e7 [PubMed]
  • Kroeze S, Ondoa P, Kityo CM, Siwale M, Akanmu S, Wellington M, de Jager M, Ive P, Mandaliya K, Stevens W, Boender TS, de Pundert ME, Sigaloff KCE, Reiss P, Wit FWNM, Rinke de Wit TF, Hamers RL, Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa. AIDS 2018;32 (8):1043-1051 [PubMed]
  • Revell AD, Wang D, Perez-Elias MJ, Wood R, Cogill D, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Rehm CA, Pozniak A, Montaner JSG, Lane HC, Larder BA [Contributors: Reiss P, van Sighem A, Montaner J, Harrigan R, Rinke de Wit T, Hamers R, Sigaloff K, Agan B, Marconi V, Wegner S, Sugiura W, Zazzi M, Kaiser R, Schuelter E, Streinu-Cercel A, Alvarez-Uria G, Perez-Elias MJ, de Oliveira T, Gatell J, Lazzari E, Gazzard B, Nelson M, Pozniak A, Mandalia S, Smith C, Ruiz L, Clotet B, Staszewski S, Torti C, Lane C, Metcalf J, Rehm CA, Vella S, Dettorre G, Carr A, Norris R, Hesse K, Vlahakis E, Tempelman H, Barth R, Wood R, Morrow C, Cogill D, Hoffmann C, Ene L, Dragovic G, Diaz R, Sucupira C, Sued O, Cesar C, Madero JS, Balavskrishnan P, Saravanan S, Emery S, Cooper D, Baxter J, Monno L, Clotet B, Picchio G, Debethune MP, Khabo P, Ledwaba L]] , 2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings. J ANTIMICROB CHEMOTH 2018;73 (8):2186-2196 [PubMed]

2017

  • Boerma RS. Prevention, suppression, and resistance: Antiretroviral treatment for children with HIV in Sub-Saharan Africa. S.l.: s.n.; 2017. 256p. [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam, onderzoek bij AIGHD, -. (Promotor(s): Rinke de Wit TF, Boele van Hensbroek M; copromotor(s): Calis JCJ, Sigaloff KCE)
  • Boerma RS, Bunupuradah T, Dow D, Fokam J, Kariminia A, Lehman D, Kityo C, Musiime V, Palumbo P, Schoffelen A, Sophan S, Zanoni B, Rinke de Wit TF, Calis JCJ, Sigaloff KCE, Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure. J INT AIDS SOC 2017;20 (1):21930-- [PubMed]
  • Boerma RS, Kityo C, Boender TS, Kaudha E, Kayiwa J, Musiime V, Mukuye A, Kiconco M, Nankya I, Nakatudde L, Mugyenyi PN, Boele van Hensbroek M, Rinke de Wit TF, Sigaloff KCE, Calis JCJ, Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance. J TROP PEDIATRICS 2017;63 (2):135-143 [PubMed]
  • Boerma RS, Sigaloff KCE, Akanmu AS, Inzaule S, Boele van Hensbroek M , Rinke de Wit TF, Calis JC, Alarming increase in pretreatment HIV drug resistance in children living in sub-Saharan Africa: a systematic review and meta-analysis. J ANTIMICROB CHEMOTH 2017;72 (2):365-371 [PubMed]
  • Kityo C, Boerma RS, Sigaloff KCE, Kaudha E, Calis JCJ, Musiime V, Balinda S, Nakanjako R, Boender TS, Mugyenyi PN, Rinke de Wit TF, Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children. J ANTIMICROB CHEMOTH 2017;72 (9):2587-2595 [PubMed]
  • Rhee SY, Varghese V, Holmes SP, van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MAA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW, Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration. EBIOMEDICINE 2017;18:225-235 [PubMed]

2016

  • Boender S. Long-term effects of HIV treatment in sub-Saharan Africa: from access to quality. S.l.: s.n.; 2016. 265p. ISBN 978-94-6169-841-4 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Rinke de Wit TF, Boele van Hensbroek M; copromotor(s): Sigaloff KCE, Calis JCJ)
  • Boender TS, Hamers RL, Ondoa P, Wellington M, Chimbetete C, Siwale M, Labib Maksimos EEF, Balinda SN, Kityo CM, Adeyemo TA, Akanmu AS, Mandaliya K, Botes ME, Stevens W, Rinke de Wit TF, Sigaloff KCE, Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa. J INFECT DIS 2016;214 (6):873-883 [PubMed]
  • Boender TS, Kityo CM, Boerma RS, Hamers RL, Ondoa P, Wellington M, Siwale M, Nankya I, Kaudha E, Akanmu AS, Botes ME, Steegen K, Calis JCJ, Rinke de Wit TF, Sigaloff KCE, Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa. J ANTIMICROB CHEMOTH 2016;71 (10):2918-2927 [PubMed]
  • Boerma RS, Boender TS, Bussink AP, Calis JCJ, Bertagnolio S, Rinke de Wit TF, Boele van Hensbroek M, Sigaloff KCE, Suboptimal Viral Suppression Rates Among HIV-Infected Children in Low- and Middle-Income Countries: A Meta-analysis. CLIN INFECT DIS 2016;63 (12):1645-1654 [PubMed]
  • Boerma RS, Boender TS, Sigaloff KCE, Rinke de Wit TF, van Hensbroek MB, Ndembi N, Adeyemo T, Temiye EO, Osibogun A, Ondoa P, Calis JC, Akanmu AS, High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children. J INT AIDS SOC 2016;19 (1):21140 [PubMed]
  • Kityo C, Sigaloff KCE, Sonia Boender T, Kaudha E, Kayiwa J, Musiime V, Mukuye A, Kiconco M, Nankya I, Nakatudde-Katumba L, Calis JCJ, Rinke de Wit TF, Mugyenyi PN, HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda. AIDS RES HUM RETROV 2016;32 (7):628-635 [PubMed]
  • Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Nelson M, Montaner JSG, Lane HC, Larder BA [Contributors: Reiss P, van Sighem A, Montaner J, Harrigan R, de Wit TR, Hamers R, Sigaloff K, Agan B, Marconi V, Wegner S, Sugiura W, Zazzi M, Kaiser R, Schuelter E, Streinu-Cercel A, Alvarez-Uria G, Gatell J, Lazzari E, Gazzard B, Nelson M, Pozniak A, Mandalia S, Webster D, Smith C, Ruiz L, Clotet B, Staszewski S, Torti C, Lane C, Metcalf J, Perez-Elias MJ, Vella S, Dettorre G, Carr A, Norris R, Hesse K, Vlahakis E, Tempelman H, Barth R, Morrow C, Wood R, Hoffmann C, Ene L, Dragovic G, Diaz R, Sucupira C, Sued O, Cesar C, Madero JS, Emery S, Cooper D, Baxter J, Monno L, Clotet B, Picchio G, Debethune MP, Khabo P, Ledwaba L]] , An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype. J ANTIMICROB CHEMOTH 2016;71 (10):2928-2937 [PubMed]

2015

  • Boender TS, Barré-Sinoussi F, Cooper D, Goosby E, Hankins C, Heidenrijk M, de Jong M, Kazatchkine M, Laoye F, Merson M, Reiss P, Rinke de Wit TF, Rogo K, Schellekens O, Schultsz C, Sigaloff KCE, Simon J, Zewdie D, Research in action: from AIDS to global health to impact. A symposium in recognition of the scientific contributions of Professor Joep Lange. ANTIVIR THER 2015;20 (1):101-108 [PubMed]
  • Boender TS, Hoenderboom BM, Sigaloff KCE, Hamers RL, Wellington M, Shamu T, Siwale M, Labib Maksimos EEF, Nankya I, Kityo CM, Adeyemo TA, Akanmu AS, Mandaliya K, Botes ME, Ondoa P, Rinke de Wit TF, Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa. CLIN INFECT DIS 2015;61 (11):1749-1758 [PubMed]
  • Boender TS, Sigaloff KCE, McMahon JH, Kiertiburanakul S, Jordan MR, Barcarolo J, Ford N, Rinke de Wit TF, Bertagnolio S, Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. CLIN INFECT DIS 2015;61 (9):1453-1461 [PubMed]
  • Boerma RS, Boender TS, Boele van Hensbroek M, Rinke de Wit TF, Sigaloff KCE, Sequencing paediatric antiretroviral therapy in the context of a public health approach. J INT AIDS SOC 2015;18 (6):24-29 [PubMed]
  • Sigaloff KCE, de Wit TFR, ART in sub-Saharan Africa: the value of viral load monitoring. LANCET HIV 2015;2 (7):e261-e262 [PubMed]

2014

  • Lamorde M, Fillekes Q, Sigaloff K, Kityo C, Buzibye A, Kayiwa J, Merry C, Nakatudde-Katumba L, Burger D, Rinke de Wit TF, Therapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid chromatography and a low cost thin-layer chromatography technique. BMC INFECT DIS 2014;14:473 [PubMed]
  • Nichols BE, Sigaloff KCE, Kityo C, Hamers RL, Baltussen R, Bertagnolio S, Jordan MR, Hallett TB, Boucher CAB, de Wit TFR, van de Vijver DAMC, Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study. J INT AIDS SOC 2014;17 (1):19164 [PubMed]
  • Nichols BE, Sigaloff KCE, Kityo C, Mandaliya K, Hamers RL, Bertagnolio S, Jordan MR, Boucher CAB, Rinke de Wit TF, van de Vijver DAMC, Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study. AIDS 2014;28 (1):73-83 [PubMed]
  • Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers R, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing A, Reiss P, van Sighem AI, Nelson M, Emery S, Montaner JSG, Lane HC, Larder BA [Contributors: Reiss P, van Sighem A, Montaner J, Harrigan R, Rinke de Wit T, Hamers R, Sigaloff K, Agan B, Marconi V, Wegner S, Sugiura W, Zazzi M, Streinu-Cercel A, Alvarez-Uria G, Gatell J, Lazzari E, Gazzard B, Nelson M, Pozniak A, Mandalia S, Ruiz L, Clotet B, Staszewski S, Torti C, Lane C, Metcalf J, Perez-Elias MJ, Carr A, Norris R, Hesse K, Vlahakis E, Tempelman H, Barth R, Morrow C, Wood R, Ene L, Dragovic G, Emery S, Cooper D, Baxter J, Monno L, Clotet B, Picchio G, Debethune MP]] , An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes. J ANTIMICROB CHEMOTH 2014;69 (4):1104-1110 [PubMed]
  • Sigaloff KCE, Lange JMA, Montaner J, Global response to HIV: treatment as prevention, or treatment for treatment?. CLIN INFECT DIS 2014;59 (Suppl. 1):S7-S11 [PubMed]

2013

  • Hamers RL, Kityo C, Sigaloff KCE, Rinke de Wit TF, Pretreatment HIV-1 drug resistance in Africa. LANCET INFECT DIS 2013;13 (6):476 [PubMed]
  • Hamers RL, Sigaloff KCE, Kityo C, Mugyenyi P, de Wit TFR, Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa. CURR OPIN HIV AIDS 2013;8 (1):19-26 [PubMed]
  • Hamers RL, Sigaloff KCE, Kityo C, Mugyenyi P, Rinke de Wit TF, HIV-1 drug resistance in antiretroviral-naive patients in sub-Saharan Africa. LANCET INFECT DIS 2013;13 (3):196-197 [PubMed]
  • Hamers RL, Zaaijer HL, Wallis CL, Siwale M, Ive P, Botes ME, Sigaloff KCE, Hoepelman AIM, Stevens WS, Rinke de Wit TF, HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes. JAIDS-J ACQ IMM DEF 2013;64 (2):174-182 [PubMed]
  • Sigaloff KCE. HIV drug resistance among adults and children in sub-Saharan Africa. s.l.: s.n.; 2013. 295p. ISBN 9789461693334 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Rinke de Wit TF; copromotor(s): van Vugt M, Calis JCJ)
  • Sigaloff KCE, Kayiwa J, Musiime V, Calis JCJ, Kaudha E, Mukuye A, Matama C, Nankya I, Nakatudde L, Dekker JT, Hamers RL, Mugyenyi P, Rinke de Wit TF, Kityo C, Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy. AIDS RES HUM RETROV 2013;29 (6):925-930 [PubMed]
  • Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, Rinke de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW, Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. J INFECT DIS 2013;207 (Suppl. 2):S70-S77 [PubMed]
  • van de Vijver DAMC, Nichols BE, Abbas UL, Boucher CAB, Cambiano V, Eaton JW, Glaubius R, Lythgoe K, Mellors J, Phillips A, Sigaloff KC, Hallett TB, Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models. AIDS 2013;27 (18):2943-2951 [PubMed]

2012

  • Boender TS, Sigaloff KCE, Kayiwa J, Musiime V, Calis JCJ, Hamers RL, Nakatudde LK, Khauda E, Mukuye A, Ditai J, Geelen SP, Mugyenyi P, Rinke de Wit TF, Kityo C, Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study. AIDS RES TREAT 2012;2012:817506 [PubMed]
  • Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PCK, Ngorima N, Kantipong P, Osibogun A, Lee CKC, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YMA, Schuurman R, van Vugt M, Rinke de Wit TF [Contributors: Njovu C, Labib M, Menke J, Botes ME, Conradie F, Sanne I, Wallis CL, Stevens WS, Hardman M, Ngorima N, Wellington M, Luthy R, Mandaliya K, Abdallah S, Jao I, Dolan M, Kityo C, Namayanja G, Nakatudde L, Kiconco M, Abwola M, Mugyenyi P, Kaleebu P, Osibogun A, Akanmu S, Wensing AM, Derdelinckx I, Schuurman R, Hamers RL, Sigaloff K, Straatsma E, van Vugt M, Rinke de Wit TF, Li PCK, Lee MP, Wong KH, Kumarasamy N, Saghayam S, Pujari S, Joshi K, Merati TP, Yuliana F, Lee CKC, Low LL, Kamarulzaman A, Ong LY, Mustafa M, Nordin N, Ditangco R, Bantique RO, Chen YMA, Wong WW, Yang YW, Phanuphak P, Sirivichayakul S, Sungkanuparph S, Piyavong B, Sirisanthana T, Praparattanapan J, Kantipong P, Kambua P, Choi JY, Han SH, Ratanasuwan W, Sriondee R, Kantor R, Sohn AH, Messerschmidt L, Singtoroj T, Cooper DA, Law MG, Jiamsakul A, Zhou J]] , Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. INT J EPIDEMIOL 2012;41 (1):43-54 [PubMed]
  • Hamers RL, Schuurman R, Sigaloff KCE, Wallis CL, Kityo C, Siwale M, Mandaliya K, Ive P, Botes ME, Wellington M, Osibogun A, Wit FW, van Vugt M, Stevens WS, de Wit TFR, Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study. LANCET INFECT DIS 2012;12 (4):307-317 [PubMed]
  • Hamers RL, Sigaloff KCE, Wensing AM, Wallis CL, Kityo C, Siwale M, Mandaliya K, Ive P, Botes ME, Wellington M, Osibogun A, Stevens WS, Rinke de Wit TF, Schuurman R [Contributors: Siwale M, Njovu C, Labib M, Menke J, Botes ME, Conradie F, Ive P, Sanne I, Wallis CL, Letsoalo E, Stevens WS, Hardman M, Wellington M, Luthy R, Mandaliya K, Abdallah S, Jao I, Dolan M, Kityo C, Namayanja G, Nakatudde L, Nankya I, Kiconco M, Abwola M, Mugyenyi P, Osibogun A, Akanmu S, Schuurman R, Wensing AM, Hamers RL, Sigaloff KCE, Straatsma E, Wit FW, Dekker J, van Vugt M, Lange JM, Rinke de Wit TF]] , Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies. CLIN INFECT DIS 2012;54 (11):1660-1669 [PubMed]
  • Hamers RL, Straatsma E, Kityo C, Wallis CL, Stevens WS, Sigaloff KCE, Siwale M, Conradie F, Botes ME, Mandaliya K, Wellington M, Osibogun A, van Vugt M, Rinke de Wit TF, Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance Network. CLIN INFECT DIS 2012;54 (4):S261-S265 [PubMed]
  • Sigaloff KCE, Hamers RL, Menke J, Labib M, Siwale M, Ive P, Botes ME, Kityo C, Mandaliya K, Wellington M, Osibogun A, Geskus RB, Stevens WS, van Vugt M, Rinke de Wit TF, Early Warning Indicators for Population-Based Monitoring of HIV Drug Resistance in 6 African Countries. CLIN INFECT DIS 2012;54 (4):S294-S299 [PubMed]
  • Sigaloff KCE, Hamers RL, Wallis CL, Kityo C, Siwale M, Ive P, Botes ME, Mandaliya K, Wellington M, Osibogun A, Stevens WS, van Vugt M, Rinke de Wit TF, Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa. J INFECT DIS 2012;205 (11):1739-1744 [PubMed]
  • Sigaloff KCE, Mandaliya K, Hamers RL, Otieno F, Jao IM, Lyagoba F, Magambo B, Kapaata A, Ndembi N, Rinke de Wit TF, Short Communication High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, Kenya. AIDS RES HUM RETROV 2012;28 (9):833-837 [PubMed]
  • Sigaloff KCE, Ramatsebe T, Viana R, de Wit TFR, Wallis CL, Stevens WS, Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South Africa. AIDS RES HUM RETROV 2012;28 (2):171-175 [PubMed]

2011

  • Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff KCE, Nankya I, Schuurman R, Wit FW, Stevens WS, van Vugt M, de Wit TFR [Contributors: Mandaliya K, Abdallah S, Jao I, Dolan M, Schuurman R, Wensing AM, Hamers RL, Sigaloff KCE, Straatsma E, Wit FW, van Vugt M, Lange JM, Rinke de Wit TF, Osibogun A, Akanmu S, Botes ME, Conradie F, Ive P, Sanne I, Wallis CL, Letsoalo E, Stevens WS, Hardman M, Kityo C, Namayanja G, Nakatudde L, Nankya I, Kiconco M, Abwola M, Mugyenyi P, Ndembi N, Lyagoba F, Kaleebu P, Siwale M, Njovu C, Labib M, Menke J, Wellington M, Luthy R]] , HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. LANCET INFECT DIS 2011;11 (10):750-759 [PubMed]
  • Ndembi N, Hamers RL, Sigaloff KCE, Lyagoba F, Magambo B, Nanteza B, Watera C, Kaleebu P, Rinke de Wit TF, Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala. AIDS 2011;25 (7):905-910 [PubMed]
  • Sigaloff KCE, Calis JCJ, Geelen SP, van Vugt M, de Wit TFR, HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review. LANCET INFECT DIS 2011;11 (10):769-779 [PubMed]
  • Sigaloff KCE, Hamers RL, Wallis CL, Kityo C, Siwale M, Ive P, Botes ME, Mandaliya K, Wellington M, Osibogun A, Stevens WS, van Vugt M, Rinke de Wit TF, Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa. JAIDS-J ACQ IMM DEF 2011;58 (1):23-31 [PubMed]

2007

  • Brouwer AE, Siddiqui AA, Kester MI, Sigaloff KCE, Rajanuwong A, Wannapasni S, Chierakul W, Harrison TS, Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitis. J INFECTION 2007;54 (3):e165-e168 [PubMed]
  • Sigaloff KCE, de Fijter CWH, Herpes zoster-associated encephalitis in a patient undergoing CAPD: case report and literature review. PERITON DIALYSIS INT 2007;27 (4):391-394 [PubMed]

2005

  • Sigaloff KCE, van den Berg JG, Benninga MA, Cecal diverticulitis in an adolescent. J PEDIATR GASTR NUTR 2005;40 (5):603-605 [PubMed]

2000

  • Ramirez MP, Sigaloff KC, Kubatina LV, Donahue MA, Venkatesh AK, Albert MS [Contributors: Albert MS]] , Physiological response of rats to delivery of helium and xenon: implications for hyperpolarized noble gas imaging. NMR BIOMED 2000;13 (4):253-264 [PubMed]